Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

16 Dec 2013 07:00

RNS Number : 5455V
Impellam Group plc
16 December 2013
 



 

 

Impellam Group plc ("Impellam" or the "Company" or "Group")

 

Pre close trading statement

 

Impellam is pleased to announce that trading during the second half of the year reflects the improving economic conditions in the Group's key markets. Our staffing businesses are all expected to see year over year growth in net fees in the second half of the year with both our UK Staffing and US Staffing business seeing full year on year growth.

 

The Group is planning to capitalise on the opportunities available in both the managed services and specialist staffing markets. Both the UK and the US Staffing businesses are keen to accelerate investment in headcount which will lead to upward cost pressure.

 

Whilst we anticipate year on year growth in operating profits in both our UK and US Staffing businesses, the costs associated with both enhanced compliance requirements and the sourcing of medical professionals is still depressing net fee conversion in our Medacs business. Accordingly, Medacs will report year on year operating profit contraction in the second half, albeit at a slower rate than we saw in the first half.

 

The Group's staffing businesses, in total, are therefore expected to see a small year on year decrease in operating profits. However, the outlook is promising with increased activity and recovering markets.

 

Trading in our Carlisle Support Services business has shown some early signs of improvement. Changes to the management structure announced at the half year are starting to deliver the benefits we anticipated in the mobilisation of high volume labour solutions to the retail, transport and logistics sectors. Whilst second half trading will not show any material improvement due to restructure costs, the outlook is more favourable. However, the business has two long term contracts, one a substantial first generation out sourcing agreement, which have proven to be operationally complex, badly priced and financially onerous. In accordance with accounting standards, full provision will be made for the costs of the exiting of one and the future ongoing losses of the other. The total provision, amounting to some £13.0 million, will be taken as an exceptional item. Having carefully reviewed the contracts portfolio, we are satisfied that no other similar contracts exist in the Group.

 

Total Group adjusted operating profit is expected to be about £5.0 million lower than the comparative period last year.

 

During the year, Impellam has returned £19.8 million to shareholders in dividends. The return of cash to shareholders remains a key objective for the Group. A final dividend of 7.0p per share will be recommended. Further details of this will be announced in due course.

 

Enquiries: For further information please contact the appropriate individual below.

 

 

Impellam Group plc

Andrew Wilson

Julia Robertson

Andrew Burchall Tel: 01582 692658

 

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

Elizabeth Bowman

 

 

Note to Editors:

 

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,500 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 17th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEXLFFXLFXFBF
Date   Source Headline
2nd Sep 20217:00 amRNSTransaction in Own Shares
31st Aug 20217:00 amRNSTransaction in Own Shares
26th Aug 20217:00 amRNSTransaction in Own Shares
25th Aug 20217:00 amRNSTransaction in Own Shares
23rd Aug 20217:00 amRNSTransaction in Own Shares
17th Aug 202110:55 amRNSTransaction in Own Shares
12th Aug 20217:00 amRNSTransaction in Own Shares
9th Aug 202110:12 amRNSTransaction in Own Shares
6th Aug 20217:00 amRNSTransaction in Own Shares
5th Aug 20219:24 amRNSTransaction in Own Shares
29th Jul 20217:00 amRNSINTERIM RESULTS TO 2 JULY 2021
5th Jul 20214:00 pmRNSHolding(s) in Company
30th Jun 202110:45 amRNSResult of AGM
28th Jun 20217:00 amRNSTransaction in Own Shares
25th Jun 20217:00 amRNSTransaction in Own Shares
21st Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20219:00 amRNSTransaction in Own Shares
14th Jun 20217:00 amRNSTransaction in Own Shares
10th Jun 20217:00 amRNSTransaction in Own Shares
19th May 20217:00 amRNSTransaction in Own Shares
17th May 20219:36 amRNSTransaction in Own Shares
10th May 20217:00 amRNSTransaction in Own Shares
26th Apr 20217:00 amRNSTransaction in Own Shares
21st Apr 20219:15 amRNSTransaction in Own Shares
20th Apr 20217:00 amRNSTransaction in Own Shares
19th Apr 20219:49 amRNSTransaction in Own Shares
13th Apr 20217:00 amRNSTransaction in Own Shares
9th Apr 20217:00 amRNSTransaction in Own Shares
8th Apr 20217:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 1 January 2021
6th Apr 20214:31 pmRNSTransaction in Own Shares
29th Mar 20217:00 amRNSTransaction in Own Shares
25th Mar 20217:00 amRNSTransaction in Own Shares
19th Feb 20217:00 amRNSTransaction in Own Shares
16th Feb 20219:05 amRNSTransaction in Own Shares
15th Feb 20217:00 amRNSTransaction in Own Shares
11th Feb 20217:00 amRNSTransaction in Own Shares
10th Feb 20217:00 amRNSTransaction in Own Shares
9th Feb 20217:00 amRNSTransaction in Own Shares
8th Feb 20217:00 amRNSTransaction in Own Shares
5th Feb 20217:00 amRNSTransaction in Own Shares
4th Feb 20217:00 amRNSTransaction in Own Shares
3rd Feb 20217:00 amRNSTransaction in Own Shares
28th Jan 20217:00 amRNSTransaction in Own Shares
26th Jan 20217:00 amRNSTransaction in Own Shares
25th Jan 20217:00 amRNSShare Purchase Plan
21st Jan 20219:50 amRNSHolding(s) in Company
4th Nov 20204:43 pmRNSDirector/PDMR Shareholding
7th Oct 20204:15 pmRNSDirector/PDMR Shareholding
31st Jul 20207:38 amRNSINTERIM RESULTS TO 3 JULY 2020
21st Jul 20205:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.